SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.9 CNY | -3.78% |
|
+16.80% | -6.89% |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 4,503 |
| Enterprise Value (EV) 1 | 3,515 |
| P/E ratio | 22.4 x |
| Yield | - |
| Capitalization / Revenue | 2.58 x |
| EV / Revenue | 2.01 x |
| EV / EBITDA | 14.4 x |
| EV / FCF | -3,054 x |
| FCF Yield | -0.03% |
| Price to Book | 1.77 x |
| Nbr of stocks (in thousands) | 191,459 |
| Reference price 2 | 23.52 |
| Announcement Date | 4/19/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 1,279 | 1,586 | 1,847 | 1,748 |
| EBITDA 1 | 162.4 | 198.3 | 229.6 | 244.4 |
| EBIT 1 | 118.8 | 153.8 | 177.6 | 185.7 |
| Operating Margin | 9.29% | 9.7% | 9.62% | 10.62% |
| Earnings before Tax (EBT) 1 | 119.6 | 142.5 | 188.8 | 176.6 |
| Net income 1 | 97.75 | 123.9 | 168 | 150.3 |
| Net margin | 7.64% | 7.81% | 9.1% | 8.6% |
| EPS 2 | 0.6800 | 0.8600 | 1.170 | 1.050 |
| Free Cash Flow 1 | 29.71 | -28.58 | -0.4157 | -1.151 |
| FCF margin | 2.32% | -1.8% | -0.02% | -0.07% |
| FCF Conversion (EBITDA) | 18.29% | - | - | - |
| FCF Conversion (Net income) | 30.39% | - | - | - |
| Dividend per Share 2 | 0.5000 | 0.4000 | 0.3000 | - |
| Announcement Date | 11/23/23 | 11/23/23 | 11/23/23 | 4/19/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | 111 | 18.8 | 3.1 | 988 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | 29.7 | -28.6 | -0.42 | -1.15 |
| ROE (net income / shareholders' equity) | 16.4% | 18.7% | 22.5% | 11.2% |
| ROA (Net income/ Total Assets) | 9.82% | 11.1% | 10.5% | 7.06% |
| Assets 1 | 995.7 | 1,114 | 1,604 | 2,128 |
| Book Value Per Share 2 | 4.410 | 4.790 | 5.590 | 13.30 |
| Cash Flow per Share 2 | 0.4900 | 0.8600 | 0.6100 | 7.540 |
| Capex 1 | 72.5 | 161 | 144 | 99.7 |
| Capex / Sales | 5.67% | 10.12% | 7.8% | 5.7% |
| Announcement Date | 11/23/23 | 11/23/23 | 11/23/23 | 4/19/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -6.89% | 603M | |
| -1.22% | 95.5B | |
| -1.34% | 44.01B | |
| +12.19% | 41.41B | |
| +2.25% | 41.13B | |
| +8.32% | 39.91B | |
| -12.98% | 31.14B | |
| -5.41% | 29.23B | |
| +13.52% | 25.25B | |
| -4.79% | 23.96B |
- Stock Market
- Equities
- 603231 Stock
- Financials Solbar Ningbo Protein Technology Co., Ltd.
